Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-59,000
Closed -$1.18M 43
2022
Q3
$1.18M Sell
59,000
-95,000
-62% -$2.27M 0.51% 33
2022
Q2
$3.49M Sell
154,000
-81,500
-35% -$1.7M 1.94% 17
2022
Q1
$6.23M Hold
235,500
2.91% 12
2021
Q4
$7.49M Buy
235,500
+113,500
+93% +$3.21M 3.15% 9
2021
Q3
$2.68M Buy
+122,000
New +$2.62M 0.95% 29
2020
Q3
Sell
-460,000
Closed -$7.4M 52
2020
Q2
$7.4M Buy
+460,000
New +$6.66M 2.14% 19
2019
Q4
Sell
-69,274
Closed -$1.23M 45
2019
Q3
$1.23M Buy
+69,274
New +$1.14M 0.89% 25

Other funds holding MRUS

Acuta Capital Partners's MRUS Position: Q4 2022 in Review

Acuta Capital Partners sold out of Merus (MRUS) in Q4 2022, closing a stake of 59,000 shares — an estimated $1.18M sold.

Acuta Capital Partners first reported a position in MRUS in Q3 2019 and held it in 7 quarters. The position peaked at $7.49M in Q4 2021. 91 funds tracked by Wall St. Rank hold MRUS as of Q4 2022.

  • Acuta Capital Partners reported no remaining Merus position as of Q4 2022 after selling out during the quarter.
  • Acuta Capital Partners sold 59,000 Merus shares in Q4 2022, an estimated $1.18M.
  • Acuta Capital Partners first reported a position in Merus in Q3 2019 and held it in 7 quarters.
  • Acuta Capital Partners's Merus position peaked at $7.49M in Q4 2021.
  • 91 funds tracked by Wall St. Rank held Merus as of Q4 2022.

Based on Acuta Capital Partners's 13F filing for Q4 2022, filed 14 Feb 2023.